PAEMF
IH

Panview Asian Equity Master Fund’s iHuman IH Stock Holding History

Panview Asian Equity Master Fund’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-432,597
Closed -$7.84M – 9
2020
Q4 		$7.84M Buy
+432,597
New +$9.64M 7.29% 6

Other funds holding IH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TAMH
Taikang Asset Management (HK) Hong Kong $1B AUM 27.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Panview Asian Equity Master Fund's IH Position: Q1 2021 in Review

Panview Asian Equity Master Fund sold out of iHuman (IH) in Q1 2021, closing a stake of 432,597 shares — an estimated $7.84M sold.

Panview Asian Equity Master Fund first reported a position in IH in Q4 2020 and held it in 1 quarter. The position peaked at $7.84M in Q4 2020. 13 funds tracked by Wall St. Rank hold IH as of Q1 2021.

  • Panview Asian Equity Master Fund reported no remaining iHuman position as of Q1 2021 after selling out during the quarter.
  • Panview Asian Equity Master Fund sold 432,597 iHuman shares in Q1 2021, an estimated $7.84M.
  • Panview Asian Equity Master Fund first reported a position in iHuman in Q4 2020 and held it in 1 quarter.
  • Panview Asian Equity Master Fund's iHuman position peaked at $7.84M in Q4 2020.
  • 13 funds tracked by Wall St. Rank held iHuman as of Q1 2021.

Based on Panview Asian Equity Master Fund's 13F filing for Q1 2021, filed 4 May 2021.